Biodegradable Ocular Inserts for Sustained Delivery of Brimonidine Tartarate: Preparation and In Vitro/In Vivo Evaluation
Open Access
- 7 October 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in AAPS PharmSciTech
- Vol. 12 (4), 1335-1347
- https://doi.org/10.1208/s12249-011-9701-3
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Design and In Vitro Evaluation of Novel Sustained-Release Double-Layer Tablets of Lornoxicam: Utility of Cyclodextrin and Xanthan Gum CombinationAAPS PharmSciTech, 2009
- Preparation, In Vitro Characterization and Preliminary In Vivo Evaluation of Buccal Polymeric Films Containing ChlorhexidineAAPS PharmSciTech, 2008
- Thermal, Spectroscopic, and Mechanical Properties of Blend Films of Poly(N-Vinyl-2-Pyrrolidone) and Sodium AlginatePolymer-Plastics Technology and Engineering, 2007
- Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: A technical noteAAPS PharmSciTech, 2006
- Design and Evaluation of Soluble Ocular Drug Insert for Controlled Release of Ciprofloxacin HydrochlorideDrug Development and Industrial Pharmacy, 2006
- Improving the solubility of ampelopsin by solid dispersions and inclusion complexesJournal of Pharmaceutical and Biomedical Analysis, 2005
- Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic deliveryJournal of Microencapsulation, 2003
- A Study of the Hydrophilic Cellulose Matrix: Effect of Drugs on Swelling Properties.CHEMICAL & PHARMACEUTICAL BULLETIN, 1996
- Analogs of UK 14,304: Structural features responsible for α2 adrenoceptor activityBioorganic & Medicinal Chemistry Letters, 1995
- Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigationJournal of Controlled Release, 1995